General Information of Drug (ID: DM6L5IP)

Drug Name
Axitirome Drug Info
Synonyms CGP-26214; CGS-25845; CGS-26214
Indication
Disease Entry ICD 11 Status REF
Hyperlipidaemia 5C80 Phase 1 [1]
Cross-matching ID
PubChem CID
166559
CAS Number
CAS 156740-57-7
TTD Drug ID
DM6L5IP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dextrothyroxine Sodium DMBVEC7 High blood cholesterol level 5C80.00 Approved [2]
BCT303 DMUFY4K Hypothyroidism 5A00 Phase 2 [3]
MB-07811 DM6JTSZ Hyperlipidaemia 5C80 Phase 2 [4]
MGL-3196 DM1HC9R Familial hypercholesterolemia 5C80.00 Phase 2 [5]
VK-2809 DMY5NUR Hypercholesterolaemia 5C80.0 Phase 2 [6]
ZYT-1 DM1XOZK Lipid metabolism disorder 5C52.Z Phase 1 [3]
VK-0214 DM90GS3 X-linked Adrenoleukodystrophy 5C57 Phase 1 [7]
tiratricol DMZO6CV Wound healing EL8Y Clinical trial [8]
Cacodylate Ion DMK4XLD Discovery agent N.A. Investigative [9]
3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one DM2JBQI Discovery agent N.A. Investigative [10]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Thyroid hormone receptor beta (THRB) TTGER3L THB_HUMAN Modulator [1]

References

1 Bacterial biosensors for screening isoform-selective ligands for human thyroid receptors alpha-1 and beta-1. FEBS Open Bio. 2012; 2: 247-253.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 589).
5 Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-beta agonist. Atherosclerosis. 2013 Oct;230(2):373-80.
6 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
7 Clinical pipeline report, company report or official report of Viking Therapeutics
8 Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3. Mol Endocrinol. 1990 Feb;4(2):227-34.
9 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
10 Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80.